Cargando…

The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation

AIM/HYPOTHESIS: Efficiency in controlling chronic diseases, especially in the primary care setting, is associated with reduced rates of hospitalizations. Poorly controlled diabetes is associated with severe diabetic decompensation, such as diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic s...

Descripción completa

Detalles Bibliográficos
Autores principales: Pina, Henrique, Martins, João Dinis, Guerra, Sílvia, Aragüés, José Maria, Valadas, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Primary Care Diabetes Europe. Published by Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266494/
https://www.ncbi.nlm.nih.gov/pubmed/37353465
http://dx.doi.org/10.1016/j.pcd.2023.06.001
_version_ 1785058751417417728
author Pina, Henrique
Martins, João Dinis
Guerra, Sílvia
Aragüés, José Maria
Valadas, Cristina
author_facet Pina, Henrique
Martins, João Dinis
Guerra, Sílvia
Aragüés, José Maria
Valadas, Cristina
author_sort Pina, Henrique
collection PubMed
description AIM/HYPOTHESIS: Efficiency in controlling chronic diseases, especially in the primary care setting, is associated with reduced rates of hospitalizations. Poorly controlled diabetes is associated with severe diabetic decompensation, such as diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS). It is hypothesized that, in addition to the SARS-CoV2 pandemic, there was a parallel increase in decompensation of previously controlled chronic diseases, such as diabetes. In this work, the impact of the SARS-CoV2 pandemic on hospitalizations for severe diabetic decompensation in a Portuguese hospital was assessed. METHODS: A retrospective study by hospital clinical file consultation was performed and a cohort of 177 patients admitted to a Portuguese hospital with a diagnosis of DKA or hyperosmolar hyperglycemic state HHS, excluding SARS-CoV2 infected patients, between 2019 and 2020 was analysed. RESULTS: In the population not infected by SARS-CoV2, statistically significant differences were found in the relative number of hospitalizations (5.59 vs 3.79 hospitalizations for DKA/HHS per 1000 patients not infected with SARS-CoV2, p = 0.0093) and lethality due to DKA/HHS (0941 vs 0337 deaths from DKA/HHS per 1000 patients not infected with SARS-CoV2, p = 0.0251). This increase in hospitalizations and lethality was accompanied by a statistically significant increase in newly type 2 diabetes diagnosis in DKA/HHS hospital admissions (p = 0.0156) and by a statistically significant increase in average age of patients (56.3 ± 22.4 vs 69.1 ± 17.6, p < 0.001). DISCUSSION AND CONCLUSIONS: These results show the empirical perspective that the consequences of the pandemic also had a considerable impact on the control of chronic diseases such as diabetes, with a higher percentage of hospitalizations due to severe decompensation, especially in the elderly population.
format Online
Article
Text
id pubmed-10266494
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Primary Care Diabetes Europe. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-102664942023-06-15 The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation Pina, Henrique Martins, João Dinis Guerra, Sílvia Aragüés, José Maria Valadas, Cristina Prim Care Diabetes Brief Report AIM/HYPOTHESIS: Efficiency in controlling chronic diseases, especially in the primary care setting, is associated with reduced rates of hospitalizations. Poorly controlled diabetes is associated with severe diabetic decompensation, such as diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS). It is hypothesized that, in addition to the SARS-CoV2 pandemic, there was a parallel increase in decompensation of previously controlled chronic diseases, such as diabetes. In this work, the impact of the SARS-CoV2 pandemic on hospitalizations for severe diabetic decompensation in a Portuguese hospital was assessed. METHODS: A retrospective study by hospital clinical file consultation was performed and a cohort of 177 patients admitted to a Portuguese hospital with a diagnosis of DKA or hyperosmolar hyperglycemic state HHS, excluding SARS-CoV2 infected patients, between 2019 and 2020 was analysed. RESULTS: In the population not infected by SARS-CoV2, statistically significant differences were found in the relative number of hospitalizations (5.59 vs 3.79 hospitalizations for DKA/HHS per 1000 patients not infected with SARS-CoV2, p = 0.0093) and lethality due to DKA/HHS (0941 vs 0337 deaths from DKA/HHS per 1000 patients not infected with SARS-CoV2, p = 0.0251). This increase in hospitalizations and lethality was accompanied by a statistically significant increase in newly type 2 diabetes diagnosis in DKA/HHS hospital admissions (p = 0.0156) and by a statistically significant increase in average age of patients (56.3 ± 22.4 vs 69.1 ± 17.6, p < 0.001). DISCUSSION AND CONCLUSIONS: These results show the empirical perspective that the consequences of the pandemic also had a considerable impact on the control of chronic diseases such as diabetes, with a higher percentage of hospitalizations due to severe decompensation, especially in the elderly population. Primary Care Diabetes Europe. Published by Elsevier Ltd. 2023-06-14 /pmc/articles/PMC10266494/ /pubmed/37353465 http://dx.doi.org/10.1016/j.pcd.2023.06.001 Text en © 2023 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Brief Report
Pina, Henrique
Martins, João Dinis
Guerra, Sílvia
Aragüés, José Maria
Valadas, Cristina
The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation
title The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation
title_full The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation
title_fullStr The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation
title_full_unstemmed The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation
title_short The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation
title_sort silent diabetic decompensation epidemic during the sars-cov2 pandemic – the role of primary care in early diagnosis and prevention of severe diabetic decompensation
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266494/
https://www.ncbi.nlm.nih.gov/pubmed/37353465
http://dx.doi.org/10.1016/j.pcd.2023.06.001
work_keys_str_mv AT pinahenrique thesilentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation
AT martinsjoaodinis thesilentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation
AT guerrasilvia thesilentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation
AT araguesjosemaria thesilentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation
AT valadascristina thesilentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation
AT pinahenrique silentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation
AT martinsjoaodinis silentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation
AT guerrasilvia silentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation
AT araguesjosemaria silentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation
AT valadascristina silentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation